CLASS I Device recall · Reported 9 Oct 2019 · FDA Enforcement Report

Sherpa Nx Active Guiding Catheter, 6f Scr3.5 Sh, .070" recalled

Medtronic Vascular is recalling Sherpa Nx Active Guiding Catheter, 6f Scr3.5 Sh, .070". The recall was initiated on 15 Mar 2019 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesGTIN: 00613994822604 All Lot/Serial Numbers
Quantity recalled14 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2738-2019
FDA event ID
82525
Recalling firm
Medtronic Vascular, Danvers, MA
Classification
Class I
Status
Completed
Recall initiated
15 Mar 2019
FDA classified
30 Sep 2019
Reported
9 Oct 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

15 Mar 2019Recall initiated by company
30 Sep 2019Classified by FDA+199 days
9 Oct 2019Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Product as listed by the FDA

SHERPA NX ACTIVE GUIDING CATHETER, 6F SCR3.5 SH, .070", REF SA6SCR35SH. for cardiovascular use

Where it was distributed

Worldwide distribution to US, Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hong Kong, Ireland, Italy, Kazakhstan, Luxembourg, Moldova, Netherlands, Poland, Portugal, Russian Federation, Saudi Arabia, Slovakia, South Africa, Spain, Sweden, Taiwan, and United Kingdom

Questions about this recall

Is Sherpa Nx Active Guiding Catheter, 6f Scr3.5 Sh, .070" recalled?

Yes. Medtronic Vascular recalled Sherpa Nx Active Guiding Catheter, 6f Scr3.5 Sh, .070" on 15 Mar 2019. The recall is Class I and its status is Completed. Recall number Z-2738-2019.

Why was it recalled?

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Which lots are affected?

GTIN: 00613994822604 All Lot/Serial Numbers

Where was it sold?

Worldwide distribution to US, Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hong Kong, Ireland, Italy, Kazakhstan, Luxembourg, Moldova, Netherlands, Poland, Portugal, Russian Federation, Saudi Arabia, Slovakia, South Africa, Spain, Sweden, Taiwan, and United Kingdom

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Medtronic Vascular

All 227

Other Heart & Vascular Devices recalls

All 6,199